TrialJournal of thrombosis and thrombolysis2014

Higher body weight patients on clopidogrel maintenance therapy have lower active metabolite concentrations, lower levels of platelet inhibition, and higher rates of poor responders than low body weight patients.

Henrik Wagner et al.PubMed ↗Publisher ↗

No numbers read from the abstract.